Poland's cancer immunotherapy market is expected to witness growth from $653 Mn in 2022 to $1,168 Mn in 2030 with a CAGR of 7.5% for the forecasted year 2022-30. The rising prevalence of cancer and recent advancements in the research and development of immunotherapies in Poland are driving the growth of the market. The Poland cancer immunotherapy market is segmented by type, application, and end user. Mabion, Captor Therapeutics, and Bristol-Myers Squibb are the major players in the Poland cancer immunotherapy market.
Poland's 3D imaging market is projected to grow from $0.18 Bn in 2022 to $xx Bn by 2030, registering a CAGR of xx% during the forecast period of 2022-30. The market will be driven by the rising demand for effective diagnostic technologies and advances in imaging technology. The market is segmented by product, application, by end-user & by portability. Some of the major players include GE Healthcare, Siemens Healthineers, and Philips Healthcare.
This report presents a strategic analysis of the Poland Healthcare Diagnostics Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Poland Healthcare Diagnostics Market, offering unmatched value, accuracy and expert insights.
Poland’s Artificial Intelligence (AI) in the diagnostics market is projected to grow from $5.8 Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022-30. The market will be driven by an increasing number of organizations and industries investing in AI-powered diagnostic solutions and the rising demand for advanced diagnostic solutions. The market is segmented by component & by diagnosis. Some of the major players include IBM Watson Health, Infermedica & Cardiomatics.
Poland's anti-ageing therapeutics market is expected to witness growth from $4 Mn in 2022 to $12 Mn in 2030 with a CAGR of 16.98% for the year 2022-30. The rising awareness about anti-ageing therapeutics and recent technological advancements in Poland has led to market expansion. The Poland anti-ageing therapeutics market is segmented by product, treatment, target group, type of ageing, type of molecules, mechanism of action, ingredient, and by distribution channel. Some of the major competitors in the market are Intelliseq, Pure Biologics, and NuSirt.
Poland's Artificial Intelligence (AI) In Healthcare Market is projected to grow from $0.04 Bn in 2022 to $0.81 Bn by 2030, registering a CAGR of 45.67% during the forecast period of 2022-30. The market will be driven by the increasing demand for better healthcare services, the ageing population, and the growing availability of AI-based solutions. The market is segmented by healthcare components & by healthcare applications. Some of the major players include IBM Watson Health, Google Health, Sano & Deepflare.
Poland's Dental Care Market is projected to grow from $208 Mn in 2022 to $342 Bn by 2030, registering a CAGR of 6.40% during the forecast period of 2022-2030. The market is supported by a number of factors, including an ageing population, increasing awareness of the importance of oral health, and a rise in disposable incomes. The key players in the dental care market in Poland include companies such as DENTSPLY Sirona, Straumann, and Dental-Med. Additionally, many local players such as Dental-Mikrosystem, Dental-Union and Dental-Tech also have a strong presence in the market.
By 2030, it is anticipated that the Poland Nutrition and Supplements market will reach a value of $xx Bn from $2.21 Bn in 2022, growing at a CAGR of xx% during 2022-2030. The nutrition and supplements market in Poland is primarily dominated by local players such as Walmark, Aflofarm Farmacja Polska, and Olimp Laboratories. The market for nutrition and supplements in Poland is primarily driven by an inclination towards better health infrastructure, government regulations and increasing consumer awareness of health and lifestyle. The Poland nutrition and supplements market in Poland is segmented by Type, Product, application, and Distribution Channel.
By 2030, it is anticipated that the Poland Lung Cancer Therapeutics Market will reach a value of $333 Mn from $173 Mn in 2022, growing at a CAGR of 8.6% during 2022-2030. The Lung Cancer Therapeutics Market in Poland is dominated by a few domestic pharmaceutical companies such as Adamed Group, Polpharma Group, and Gedeon Richter Polska. The Lung Cancer Therapeutics Market in Poland is segmented into different types of cancer and different therapy type. Some of the major factors affecting the Poland lung cancer therapeutics market are the prevalence of unhealthy lifestyles, demand for targeted therapies and the presence of highly efficient drugs.
By 2030, it is anticipated that the Poland liver disease therapeutics market will reach a value of $216 Mn from $134 Mn in 2022, growing at a CAGR of 6.2 % during 2022-2030. The liver disease therapeutics in Poland is dominated by a few domestic pharmaceutical companies such as Polpharma, Adamed, and Hasco-Lek. The liver disease therapeutics market in Poland is segmented into different types of disease and different therapy types. Some of the major factors affecting the market are the growing prevalence of liver diseases and unhealthy and dynamic lifestyles.
The Poland Diabetes Devices Market is expected to witness growth from $132 Mn in 2022 to $238 Mn in 2030 with a CAGR of 7.65% for the forecasted year 2022-2030. Diabetes is more common in older people, so demand for diabetes devices is anticipated to increase as Poland's population ages. The market is segmented by type and by the end user. Some key players in this market include Skamex, SORIMEX, Johnson & Johnson, Philipps Healthcare, Medtronic, Roche and Dexcom.
The Poland Cardiac Surgery Instruments Market is expected to witness growth from $12 Mn in 2022 to $21 Mn in 2030 with a CAGR of 7.05% for the forecasted year 2022-2030. Cardiovascular diseases are becoming more prevalent in Poland as the country's populace increases. Additionally, the older population has more complicated health problems, which increases the demand for cardiac surgery instruments in Poland. The market is segmented by type, application and by end user. Some key players in this market include Metrum Cryoflex, Skamex, LivaNova, B. Braun, Medline Industries, KLS Martin, and STILLE.
The Poland healthcare insurance market is projected to grow from $11.75 Bn in 2022 to $21.83 Bn by 2030, registering a CAGR of 8.05% during the forecast period of 2022 - 2030. The main factors driving the growth would be the digital health marketplace, rising healthcare costs, government policies and Technological advancements. The market is segmented by component, provider, coverage, by health insurance plans and end-user. Some of the major players include Luxmed, PZU Zdrowie, Inter Polska, Medicover and Allianz.
The Poland Biomaterials in Healthcare Market is expected to witness growth from $906 Mn in 2022 to $2522 Mn in 2030 with a CAGR of 13.65% for the forecasted year 2022-2030. Poland biomaterials manufacturers work with research organizations to create novel biomaterials or enhance existing ones. The market for biomaterials is expanding as a result of such collaboration that results in the creation of new products and invention. The market is segmented by type and by application. Some key players in this market include: NanoGroup S.A, Biovico, Matopat, BASF SE, Johnson and Johnson, Medtronic and Evonik Industries.
Poland's Attention Deficit Hyperactivity Disorder (ADHD) therapeutics market is projected to grow from $171 Mn in 2022 to $316 Mn in 2030 with a CAGR of 7.95% for the year 2022-2030. The increased prevalence of ADHD and the availability of novel therapeutic options for the treatment of ADHD in Poland are the major market drivers for the growth of the market. The Poland ADHD therapeutics market is segmented by drug, drug type, demographics, and by distribution channel. Some of the key players in the market are ALG Pharma, Techdow Pharma, and Noven Pharmaceuticals.
Poland 3D Printing Medical Device Market is expected to witness growth from $17 Mn in 2022 to $59 Mn in 2030 with a CAGR of 16.75% for the forecasted year 2022-2030. In Poland, Patients need medical devices that are specifically designed for their individual anatomical demands and medical requirements. The demand for 3D printing medical devices in Poland is being driven by manufacturers ability to create customised medical devices quickly and affordably. The market is segmented by application, by technology and by end user. Some key players in this market include: Braster S.A, Skamex, Stryker, Stratasys, GE Additive and Prodways Group.
Poland's oncology clinical trials market is projected to grow from $73.4 Mn in 2022 to $116.5 Mn by 2030, registering a CAGR of 5.95% during the forecast period of 2022-30. The market will be driven by the increased prevalence of cancer and a good regulatory framework. The market is segmented by phase, by study design & by indication. Some of the major players include Pfizer Inc., Roche Holding AG, Novartis International AG & Ryvu Therapeutics.
The Poland healthcare claims management market is projected to grow from $154.86 Mn in 2022 to $857.25 Mn by 2030, registering a CAGR of 23.85% during the forecast period of 2022 - 2030. The main factors driving the growth would be the rising demand for value-based care, the growing adoption of digital health solutions, and increasing healthcare expenditure and government initiatives. The market is segmented by component, type, by delivery mode and end-user. Some of the major players include Comarch, Minte, Crawford and Company, Infosys and Accenture.
By 2030, it is anticipated that the Poland Liver Cancer Therapeutics market will reach a value of $64.1 Mn from $17 Mn in 2022, growing at a CAGR of 18.1 % during 2022-2030. Liver Cancer Therapeutics in Poland is dominated by a few domestic pharmaceutical companies such as Polpharma Biologics, Adamed Group and Celon Pharma. The Liver Cancer Therapeutics market in Poland is segmented into different types of cancer and different therapy type. Some of the major factors affecting the Poland Liver Cancer Therapeutics market are the growing prevalence of liver cancer and the high cost and side effects related to certain liver cancer therapies.
The Poland Neurology Clinical Trials market is projected to grow from $30.3 Mn in 2022 to $48.2 Mn by 2030, registering a CAGR of 5.95% during the forecast period of 2022 - 2030. The market will be driven by a skilled workforce, a supportive regulatory framework, and a relatively low cost of conducting research. The market is segmented by phase, by study design & by indication. Some of the major players include Biogen Inc., Pfizer Inc. & Novartis AG.
By 2030, it is anticipated that the Poland infectious disease therapeutics market will reach a value of $1012 Mn from $695 Mn in 2022, growing at a CAGR of 4.8% during 2022-2030. Infectious Disease Therapeutics in Poland is dominated by a few domestic pharmaceutical companies such as Polpharma Group, Selvita and Adamed Group. The Infectious Disease Therapeutics market in Poland is segmented into different therapeutic areas and different diseases type. The major factors affecting the Poland infectious disease therapeutics market are the increasing disease burden of communicable diseases like TB, hepatitis, COVID-19, and the amount of healthcare funding for infectious diseases treatment in various areas of Poland.
The Poland Neurology Device Market is expected to witness growth from $73 Mn in 2022 to $xx Bn in 2030 with a CAGR of xx% for the forecasted year 2022-2030. The neurology devices market in Poland is expanding as a result of factors such as the prevalence of neurological conditions like dementia, Parkinson's disease, and stroke is rising in Poland as the population ages. As a result, the demand for neurology devices is rising. The market is segmented by product type and by the end user. Some key players in this market include Synektik, Skamex, Medtronic, Abbott Laboratories, GE Healthcare, Penumbra, and Boston Scientific.
The Poland patient engagement solutions market is projected to grow from $98.66 Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The main factors driving the growth would be the ageing population, growing prevalence of chronic diseases, increasing healthcare expenditure and government support. The market is segmented by component, delivery mode, application, therapeutic area, functionality and by end-user. Some of the major players include Infermedica, Comarch Healthcare, Wolter Kluwer, Oracle and IBM.
By 2030, it is anticipated that the Poland HIV therapeutics market will reach a value of $xx Mn from $79.81 Mn in 2022, growing at a CAGR of xx% during 2022-2030. The market is primarily dominated by local players such as Polpharma, Polfa Tarchomin, and Adamed. The market is driven by government policies and non-governmental organizations’ initiatives for the management of HIV infections in the country. The HIV therapeutics market in Poland is segmented by type, product, geography, end user, and distribution channel.
The Poland Palliative care market is projected to grow from $75.86 Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The main factors driving the growth would be an increase in the prevalence of chronic diseases, an aging population, and palliative care education. The market is segmented by service type and by the end user. Some of the major players include Caritas Pflege, Hospice Vorarlberg, St. Lazarus Hospice, and Warsaw Hospice for Children.